(Q42513759)

1 November 2017

title

Hyperglycaemia is associated with impaired pulsatile insulin secretion: effect of basal insulin therapy (English)

1 reference

1 November 2017

1 reference

1 reference

J J Meier

1

1 reference

1 November 2017

C Pennartz

2

1 reference

1 November 2017

N Schenker

3

1 reference

1 November 2017

B A Menge

4

1 reference

1 November 2017

W E Schmidt

5

1 reference

1 November 2017

T Heise

6

1 reference

1 November 2017

C Kapitza

7

1 reference

1 November 2017

J D Veldhuis

8

1 reference

1 November 2017

language of work or name

1 reference

1 March 2013

1 reference

Diabetes, Obesity and Metabolism

1 November 2017

published in

1 reference

1 November 2017

volume

15

1 reference

1 November 2017

issue

3

1 reference

1 November 2017

page(s)

258-263

1 reference

Pulsatile insulin secretion: detection, regulation, and role in diabetes

1 November 2017

cites work

1 reference

Pulsatile portal vein insulin delivery enhances hepatic insulin action and signaling

21 January 2018

1 reference

Augmented effect of short-term pulsatile versus continuous insulin delivery on lipid metabolism but similar effect on whole-body glucose metabolism in obese subjects.

21 January 2018

1 reference

The effect of manipulation of basal pulsatile insulin on insulin action in Type 2 diabetes

21 January 2018

1 reference

Failure of physiological plasma glucose excursions to entrain high-frequency pulsatile insulin secretion in type 2 diabetes.

21 January 2018

1 reference

Loss of beta-cell mass leads to a reduction of pulse mass with normal periodicity, regularity and entrainment of pulsatile insulin secretion in Göttingen minipigs

21 January 2018

1 reference

Mechanisms of impaired fasting glucose and glucose intolerance induced by an approximate 50% pancreatectomy

21 January 2018

1 reference

Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and beta-cell mass to age-related insulin resistance in rats

21 January 2018

1 reference

Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance

21 January 2018

1 reference

Induction of beta-cell rest by a Kir6.2/SUR1-selective K(ATP)-channel opener preserves beta-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose

21 January 2018

1 reference

Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM.

21 January 2018

1 reference

Beta-cell function improved by supplementing basal insulin secretion in mild diabetes

21 January 2018

1 reference

Chronic reduction of fasting glycemia with insulin glargine improves first- and second-phase insulin secretion in patients with type 2 diabetes

21 January 2018

1 reference

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

21 January 2018

1 reference

Deconvolution analysis of hormone data

21 January 2018

1 reference

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

21 January 2018

1 reference

Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes

21 January 2018

1 reference

Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial

21 January 2018

1 reference

Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes

21 January 2018

1 reference

The order of islet microvascular cellular perfusion is B----A----D in the perfused rat pancreas

21 January 2018

1 reference

Insulin degradation: progress and potential

21 January 2018

1 reference

Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans

21 January 2018

1 reference

The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus

21 January 2018

1 reference

Further improvement in postprandial glucose control with addition of exenatide or sitagliptin to combination therapy with insulin glargine and metformin: a proof-of-concept study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DOM.12022

1 reference

1 November 2017

1 reference